Loading...
•
Dec 31, 2020
Quanterix Q4 2020 Earnings Report
Announced Q4 2020 financial results, with non-GAAP revenue increasing by 36% compared to the prior year.
Key Takeaways
Quanterix reported Q4 GAAP revenue of $26.1 million and non-GAAP revenue of $21.6 million, representing a 36% increase compared to the previous year. The company is focusing on the long-term impact of COVID-19 on human health and scaling its operations to meet the growing demand for ultra-sensitive protein analytical tools.
Q4 GAAP revenue including Grant Revenue was $26.1M.
Q4 non-GAAP revenue was $21.6M, a 36% increase versus prior year.
The company is addressing the pandemic crisis and advances in Alzheimer's therapies.
Quanterix is scaling to support this unprecedented opportunity in precision health.
Forward Guidance
Quanterix is entering 2021 on strong footing, scaling to support the unprecedented opportunity in precision health, and focusing on analytical tools to support disease studies, diagnostics, and drug development.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...